Aptevo Therapeutics Stock Price Patterns
| APVO Stock | USD 6.76 0.78 10.34% |
Momentum 32
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (1.90) | EPS Estimate Current Year (96.84) | EPS Estimate Next Year (28.80) | Wall Street Target Price 377.9997 | EPS Estimate Current Quarter (2.09) |
Using Aptevo Therapeutics hype-based prediction, you can estimate the value of Aptevo Therapeutics from the perspective of Aptevo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aptevo Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Aptevo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aptevo Therapeutics after-hype prediction price | USD 6.76 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Aptevo Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptevo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aptevo Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Aptevo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aptevo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aptevo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aptevo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Aptevo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aptevo Therapeutics' historical news coverage. Aptevo Therapeutics' after-hype downside and upside margins for the prediction period are 0.04 and 13.48, respectively. We have considered Aptevo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aptevo Therapeutics is unstable at this time. Analysis and calculation of next after-hype price of Aptevo Therapeutics is based on 3 months time horizon.
Aptevo Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Aptevo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aptevo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aptevo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.00 | 6.75 | 0.30 | 0.12 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
6.76 | 6.76 | 0.00 |
|
Aptevo Therapeutics Hype Timeline
Aptevo Therapeutics is presently traded for 6.76. The entity has historical hype elasticity of -0.3, and average elasticity to hype of competition of -0.12. Aptevo is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -2.0%. %. The volatility of related hype on Aptevo Therapeutics is about 11421.32%, with the expected price after the next announcement by competition of 6.64. The company has price-to-book (P/B) ratio of 0.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aptevo Therapeutics recorded earning per share (EPS) of 7758.2. The entity last dividend was issued on the 27th of March 2020. The firm had 1:18 split on the 30th of December 2025. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out Aptevo Therapeutics Basic Forecasting Models to cross-verify your projections.Aptevo Therapeutics Related Hype Analysis
Having access to credible news sources related to Aptevo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Aptevo Therapeutics' future price movements. Getting to know how Aptevo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aptevo Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KPRX | Kiora Pharmaceuticals | (0.15) | 7 per month | 0.00 | (0.05) | 5.32 | (5.58) | 16.69 | |
| EPIX | ESSA Pharma | 0.02 | 3 per month | 0.00 | (0.19) | 5.00 | (5.00) | 75.44 | |
| HCWB | HCW Biologics | (0.05) | 9 per month | 0.00 | (0.23) | 13.02 | (11.97) | 41.72 | |
| ABP | Abpro Holdings | (0.01) | 9 per month | 0.00 | (0.24) | 10.52 | (11.71) | 36.77 | |
| MTNB | Matinas BioPharma Holdings | (0.05) | 7 per month | 0.00 | (0.14) | 11.67 | (10.67) | 39.32 | |
| INAB | In8bio Inc | (0.17) | 8 per month | 5.04 | 0.02 | 14.29 | (9.18) | 37.96 | |
| RADX | Radiopharm Theranostics Limited | 0.00 | 0 per month | 7.89 | 0.05 | 7.44 | (7.58) | 193.18 | |
| BCDA | Biocardia | (0.05) | 3 per month | 0.00 | (0.05) | 5.93 | (4.32) | 21.46 | |
| CERO | CERo Therapeutics Holdings | (0) | 6 per month | 0.00 | (0.09) | 20.00 | (17.65) | 94.69 | |
| ERNA | Eterna Therapeutics | (0.13) | 3 per month | 0.00 | (0.14) | 6.90 | (7.91) | 23.73 |
Aptevo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Aptevo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aptevo using various technical indicators. When you analyze Aptevo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aptevo Therapeutics Predictive Indicators
The successful prediction of Aptevo Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aptevo Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aptevo Therapeutics based on analysis of Aptevo Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aptevo Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aptevo Therapeutics's related companies. | 2025 | 2026 (projected) | Days Sales Outstanding | 263.73 | 276.91 | PTB Ratio | 0.29 | 0.27 |
Pair Trading with Aptevo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptevo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Aptevo Stock
Moving against Aptevo Stock
| 0.9 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.71 | ENGN | enGene Holdings Common | PairCorr |
| 0.71 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.71 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.69 | DSGN | Design Therapeutics | PairCorr |
The ability to find closely correlated positions to Aptevo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptevo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptevo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptevo Therapeutics to buy it.
The correlation of Aptevo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptevo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptevo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptevo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aptevo Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Will Biotechnology sector continue expanding? Could Aptevo diversify its offerings? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aptevo Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Aptevo Therapeutics requires distinguishing between market price and book value, where the latter reflects Aptevo's accounting equity. The concept of intrinsic value - what Aptevo Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Aptevo Therapeutics' price substantially above or below its fundamental value.
Understanding that Aptevo Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aptevo Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aptevo Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.